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Summary 31P-NMR surface coil spectra of three subcutaneously implanted rat tumours (Morris
hepatoma 7777, GH3 prolactinoma, Walker carcinosarcoma) and an N-methyl-N-nitrosourea induced rat
mammary adenocarcinoma at different stages of growth were obtained and compared with histological
sections taken immediately after NMR acquisitions. Metabolite ratios (phosphocreatine (PCr)/Pnucleoside
triphosphate (PNTP), PCr/Pi, PNTP/Pi) calculated from the NMR spectra were compared with ratios obtained
from acid extracts of tumours of similar size. Measurements of creatine and ADP were also made. Three of
the tumours showed positive correlations between increasing tumour size and decreasing metabolite ratios
measured both by NMR and in extracts, whereas the Walker carcinosarcoma showed no correlation between
size and any parameters measured. Phosphorus metabolite ratios, measured in extracts of skin overlying the
tumours, indicated a fall in high energy phosphate when there was histological evidence of skin invasion by
the tumour. Surface coil 31P-NMR spectra of subcutaneously grown or induced tumours in the rat represent a
slowly changing steady state as the tumour increases in size. We conclude that increasing numbers of hypoxic
tumour cells, rather than large areas of necrotic tissue, contribute largely to the NMR spectrum.
3'P-NMR spectroscopy has been used to monitor growth and
response to therapy in several experimental tumour lines (Ng
et al., 1982; Steen et al., 1988; Wehrle et al., 1987; Rodrigues
et al., 1988; Tozer et al., 1989). Tumour response to various
types of chemotherapy and X-irradiation therapy often
involves the reversal of the changes seen during untreated
progression; the treated tumour appears more highly ener-
gised (i.e. has increased phosphocreatine/pnucleoside triphos-
phate (PCr/PNTP), PCr/Pi or PNTP/Pi; see Methods) than
before treatment.
The changes in the 3'P-NMR spectra that occur as animal
tumours grow could be due to several causes. Most tumours
described in the literature have shown a fall in high energy
phosphates with increasing age and size which is usually
attributed to increasing hypoxic or necrotic fractions (Ng et
al., 1982; Rofstad et al., 1988a). Other factors, such as host
cell invasion, oedema, haemorrhage and cyst formation, will
also affect the spectrum.
Our recent studies (Stubbs et al., 1988a, 1989) on the
contribution of rat skin to surface coil spectra of subcu-
taneous tumours suggest that this, too, could be important in
studies on animals.
If the tumour invades and destroys the skin (and partic-
ularly the panniculus carnosus muscle which forms a major
part of rodent skin) the skin contribution to the 3'P-NMR
spectrum will decrease with increasing tumour size. In order
to elucidate these processes we have embarked on a series of
studies of tumour growth.
Here we report the results of NMR studies of a variety of
subcutaneously implanted rat tumours in vivo, at different
time points in their growth, where we have compared the
NMR spectra with histological sections of the tumours and
with results obtained by hplc and enzymatic assay of acid
extracts of the tumours. The tumours studied include Morris
hepatoma 7777, the GH3 prolactinoma, the Walker car-
cinosarcoma and the NMU-induced mammary adenocar-
cinoma.
In addition we have freeze-clamped and measured phos-
phate metabolites in acid extracts of the tissues overlying
some of the subcutaneous tumours.
There are several difficulties associated with such a study.
First, freeze clamping needs to be done rapidly in order to
minimise breakdown of high energy phosphates and because
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of tumour heterogeneity it is necessary to extract the whole
tumour for analysis. Therefore it is only possible to do either
NMR and histology or NMR and freeze clamping. This
means that comparisons sometimes have to be made between
different tumours, albeit of a similar size. Secondly, when
making comparisons between NMR and extract data there is
only one parameter, PCr/NTP, that is truly comparable since
only PCr and NTP are 'free' and therefore quantifiable both
by NMR and in extracts (unlike nucleoside diphosphate
(NDP) and Pi of which significant proportions are known to
be bound and therefore NMR invisible in tissues such as
muscle, liver and kidney (Gadian, 1982; Iles et al., 1985;
Freeman et al., 1983); see also Results section of this paper).
For these and other reasons (including lack of the metabolite
in question, poor resolution in the NMR spectrum, etc.), we
have compared trends in the energy status of the tumours by
means of several different ratios in addition to PCr/NTP. It
is assumed that, in tumours that contain adequate creatine
kinase activity, there will be an equilibrium relationship
between cytosolic PCr, creatine (Cr), NTP and NDP so that
PCr/Cr, and NTP/NDP will reflect changes in PCr/NTP; in
tumours that do not contain creatine kinase comparisons are
limited to NTP/NDP and NTP/Pi.
Preliminary accounts of this work have been presented
(Stubbs et al., 1988b, c).
Methods
Tumours
Each batch of tumours (Morris Hepatoma 7777, GH3 pro-
lactinoma, Walker carcinosarcoma; for details of tumours see
Stubbs et al., 1989) was grown up from a single inoculum or
induced by N-methyl-N-nitrosourea (NMU) injection (mam-
mary adenocarcinoma; see Williams et al., 1981). There were
at least 10 in each batch for the prolactinoma, Walker car-
cinosarcomas and mammary adenocarcinomas, six in one
Morris hepatoma 7777 batch and five in another. Tumours
were chosen in pairs in increasing sizes; one for the NMR
study which was taken for histology after the completion of
the NMR collection and one of similar size which was freeze-
clamped, acid extracted and assayed for high energy phos-
phates. Tumour volumes were measured using the formula:
V=n/6dl . d2 . d3
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NMR measurements
The NMR was performed on a 1.89T-TMR 32200 spect-
rometer with a 27 cm horizontal bore, from Oxford Research
Systems, Abingdon, UK. Spectra were obtained from each
batch of tumours with a surface coil (Ackerman et al., 1980),
either 1, 1.4 or 2 cm diameter, with a 6, 8 or 10 s pulse
duration respectively. The 900 pulses for these coils at the coil
centre were 4, 6 and 6 ,is respectively. The repetition time
was 3 s and 480 scans were collected routinely. Exponential
weighting equivalent to 15 Hz line broadening and decon-
volution with a function to reduce broad spectral lines was
applied before integration of the peaks using the software
package supplied with the machine (for further details see
Rodrigues et al., 1988). To test the reproducibility of this
method we made repeated measurements on two tumours. In
the Walker carsinosarcoma the mean (±s.d.) PNTP/Pi ratio
was 0.61±0.05 (n = 7) and in a Morris hepatoma it was
0.47 ±0.04 (n = 6). However, due to difficulties in baseline
definition and overlapping peaks these integrals may not give
true chemical concentrations. For this reason the data in this
paper are all expressed as ratios of integrals (except in Table
IV), which minimises some of the uncertainties.
The ATP signals of tumours co-resonate with those of
GTP and the other nucleoside triphosphates. The P peak
contains only triphosphate signal so we refer to PNTP in
spectral quantitation. In hplc studies of extracts we found
that ATP and GTP were the main nucleoside triphosphates
so to make the extract results compatible with NMR data,
concentrations are reported as NTP. Similarly NDP is the
sum of ADP + GDP in extracts.
pH measurements
pH was calculated from the chemical shift of Pi by the
method of Prichard et al. (1983). These measurements were
referenced to PCr at Op.p.m. when it was present and to
aNTP at -7.57p.p.m. when PCr was negligible. The rep-
roducibility of this measurement was assessed by repeated
measurements on a Walker carcinosarcoma that contained
both aNTP and PCr. The pH was 7.32±0.1 (mean ± s.d.)
when referenced to PCr and 7.41 ± 0.12 when referenced to
aNTP. The two means were not significantly different by a
paired t test (P>O.1). Absolute accuracy of the pH measure-
ment was difficult to assess since there is no other non-
invasive method available for comparison.
Acid extracts of tumours and overlying tissues
Skin tissues were rapidly excised from over the tumour with
sharp curved scissors and dropped into liquid N2. The
tumour was then excised and freeze clamped in pre-cooled
aluminium tongs. The whole procedure took less than 15 s.
The frozen tissues were extracted with perchloric acid and
neutralised as described in Stubbs et al. (1988a).
Measurements ofphosphocreatine, creatine and Pi
PCr and Cr were assayed enzymatically on neutralised per-
chloric acid extracts by the method described in Bergmeyer
(1974) and Pi by the method of Lowry and Lopez (1946) as
modified by Chandra Rajan and Klein (1976).
Adenine nucleotides
These were assayed in neutralised extracts by hplc with a
hypersil-APS (5p) weak anion exchange column and a
Waters Instrument. A linear phosphate gradient from 22 mM
to 0.7M was used, prepared from Aristar potassium phos-
phate (Shuttlewood & Griffiths, 1982).
Histological sections
A section, orthogonal to the plane of the coil, was taken
through the centre of the tumour, including the skin, immed-
iately after the NMR acquisition. Sections were cut from
these specimens and fixed in 25% formal saline and subse-
quently cut and stained with Haematoxylin & Eosin.
Results
GH3prolactinoma
The NMR spectra showed seven clear peaks of which only
PCr appeared to change consistently with increasing size of
tumours (for representative spectra see Figure la-c). In the
largest tumour 17.6 cm3; Figure Ic) the PCr resonance had
virtually disappeared. Histological sections (see Figure Id for
a tumour of 6.1 cm3) showed little infiltration of the dermis
or panniculus carnosus muscle except in the largest tumour
(Figure le) which also showed myolysis of muscle tissue. The
amount of necrotic tissue in the tumours was small; it repre-
sented only about 10% in a tumour of 17.6 cm3. There was
some evidence of a granulomatous reaction in the subcutis in
response to the presence of the implanted tumour cells to-
gether with some inflammatory cell infiltration of the sur-
rounding tissues.
Comparisons ofNMR spectra with acid extracts ofthe
prolactinomas
PCr/PNTP ratios calculated from both the peak areas in the
NMR spectra and in the acid extracts (Table I) decreased
significantly with increasing tumour volume (for correlation
coefficients see Table III).
There was a less marked but still significant decrease in
,BNTP/Pi measured from the NMR spectra. PCr/Cr and
NTP/NDP measured in the acid extracts also correlated with
the increase in tumour size (Table III). Cr was consistently
present in all sizes of this tumour. Tumour pH calculated
from the chemical shift of Pi in the NMR spectrum ranged
between 7.1 and 7.5 but showed no correlation with size.
Morris hepatoma 7777
Tumours were studied at various times after implantation
when they had reached sizes ranging from 3 to 29 cm3. In the
NMR spectra of these tumours the Pi peak increased with
size (for two representative spectra see Figure 2). No PCr
resonance was observed except in the smallest tumour (not
shown in Figures).
Histological sections showed that as the tumour grew the
cutis became thin and histological evidence of panniculus
carnosus muscle, which was present in a tumour of 12.4 cm3
(Figure 2c), had disappeared in a tumour of 21 cm3 (not
shown in the Figure). The foci of tumour cell necrosis were
much more extensive in the hepatomas than in the prolac-
tinomas (compare Figure le with Figure 2c).
Comparison ofNMR spectra with acidextracts ofhepatoma
7777
Since the acid extracts showed no detectable PCr or Cr at
any time there is no directly comparable ratio between the
NMR and the acid extract data. However, the significant
decrease in PNTP/Pi observed with increasing tumour size
(for correlation coefficients see Table III) was mirrored by a
fall in the NTP measured in the acid extract from 1.23 tmol
g-' in the smallest tumour to 0.6jmmolg' in the largest
tumour and also by a fall in the NTP/NDP ratio. pH varied
between 7.1 and 7.6 with no apparent correlation to size of
tumour.
NMU-induced mammary adenocarcinomas
A distinct PCr resonance was observed in the NMR spectra
of three tumours of 1.4, 2.1 and 7.4 cm3. In tumours larger
than 7.4 cm3 and in one of 3.9 cm3, the phosphocreatine
resonance was negligible (spectra of typical mammary adeno-RAT TUMOUR 31P-NMR, HISTOLOGY AND EXTRACTS 703
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Figure 1 31P-NMR spectra and histology of GH3 prolactinoma. Peak assignments as follows: (I) P phosphate of NTP; (2) a
phosphate of NTP, a phosphate of NDP, NAD; (3) y phosphate of NTP, i phosphate of NDP; (4) phosphocreatine; (5)
phosphodiester; (6) Pi; (7) phosphomonoester. a is a spectrum from a tumour of 0.77 cm3, b and d from a tumour of 6.1 cm3 and c
and e from a tumour of 17.6cm3. The relative position of the coil is marked with open circles. The photographs are from the
sections marked on the histological drawings and are x 11. The key to the histological drawing is as follows: A, epidermis/dermis;
C, panniculus carnosus muscle; D, actively growing tumour tissue; E, necrotic tumour tissue; F, subcutis showing inflammatory cell
infiltration; G, granulomatous reaction in subcutis.
TableI HighenergyphosphatesandCrconcentration inGH3prolactinomasofdifferent
sizes
NMR measurements Acid extracts a
Size of Size of Cr conc.
tumour (cm3) PCr/IPNTP fNTP/Pi tumour (cm3) PCr/NTP
b pmolg ' wet wt
0.77 1.42 1.10 1.10 1.21 3.35
2.9 0.96 1.38 2.80 0.52 2.19
6.1 0.50 1.30 6.10 0.79 2.26
10.7 0.83 0.90 10.8 0.34 2.89
17.6 0.46 0.62
'Metabolite range (smol g-'wet wt) PCr, 0.12-1.35; NTP, 0.35-1.12. bhplc distin-
guishes between the different triphosphates ofwhich ATP is the biggest contributor and
GTP the next (the others are <5%). Forthis reason NTP in the tumour extractshas been
calculated from ATP + GTP in order to make comparisons with NMR data.
carcinomas have been shown in Rodrigues et al. (1988)).
Histological sections of the tumours (and overlying skin)
showed that the smallest tumour was growing actively with
no necrosis. In the larger tumours the subcutis contained a
granulomatous reaction. In three of the tumours there was
evidence of invasion of the panniculus carnosus muscle by
the adenocarcinoma and small areas of necrosis were appar-
ent. There was also a chronic inflammatory response in the
dermis. In the largest tumour studied (16 cm3) there was
ulceration of the overlying epidermis but the large tumour
masses were not necrotic.
Comparison ofNMR with acid extract data in mammary
adenocarcinomas
The PCr/,BNTP and ,NTP/Pi ratios calculated from peak
areas of the NMR spectra (Table II) decreased significantly
with increasing tumour size. This finding was mirrored by the
PCr/NTP ratios in extracts of mammary adenocarcinomas of
similar size although significance was not achieved (see Table
III). However, the trend of decreasing high energy phos-
phates with increasing tumour size was evident, especially in
the extract PCr/Cr ratio where it was statistically significant
(see also Table III). Cr was consistently present in this
tumour and pH ranged between 7.0 and 7.5.
Walker carcinosarcoma
Two batches of tumours (a total of nine) ranging from 2.5 to
27.5 cm3 were examined by NMR. Figure 3a shows the
NMR spectrum and Figure 3b the histological section of a
tumour (6.2 cm3) in the range studied (2.6-20.4 cm3). His-
tological sections showed evidence of a granulomatous reac-
tion in the subcutis in response to the presence of implanted
tumour cells with some inflammatory cell infiltration of the
surrounding tissues (Figure 3b). In the largest tumour there
were large areas of cellular necrosis. There were, however, no
differences in the histological structures of the actively grow-
ing tumour aggregates.
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Figure 2 3`P-NMR spectra and histology of Morris Hepatoma
7777. Details as Figure 1. a and c from a tumour of 12 cm3, b
from a tumour of 21 cm3.
All the acid extracts of the Walker carcinosarcomas
studied contained PCr (range 0.1-1.0 iimol g-' wet wt) and
Cr (range 0.5-2.8 tmol g-' wet wt) but some had strong PCr
signals in vivo whereas in others PCr was negligible. Of nine
tumours examined in vivo, four had a significant PCr signal
(PCr/PNTP = 0.64 ± 0.14) and in five it was negligible. Acid
extracts of 10 tumours from a similar size range had a more
uniform distribution of PCr/NTP values (mean PCr/
NTP = 0.38 ± 0.08). None of the spectral parameters mea-
sured showed any correlation with growth and similarly in
the acid extracts there was no correlation between the size of
tumourandeitherPCr, Cr, NTP orNDP(seeTable III). ThepH
of these tumours ranged from 7.2 to 7.7.
Because of the lack of correlation between size and any
parameter measured in the Walker carcinosarcomas we
studied a single tumour throughout its growth by NMR
alone. This study showed that PNTP/Pi values, calculated
from the NMR spectra of a tumour that increased from 1.8
to 29.5 cm3 over a period of 6 days, also did not correlate
with increasing size (P>0.1).
General comparisons between NMR and extract data
Pi measured in extracts of Walker carcinosarcomas and
mammary adenocarcinomas was consistently higher than that
measured by NMR (Table IV). This finding has been made
in a number of normal tissues and is thought to be due to
binding or compartmentalisation of Pi in vivo causing it to be
NMR invisible (Ross et al., 1984; Iles et al., 1985) although
in contrast Corbett et al. (1987) found more Pi in vivo than in
vitro in a human melanoma grown in nude mice.
In tumours containing PCr it was possible to calculate
'free' ADP (assuming equilibrium in the creatine kinase reac-
tion) from the extract measurements of PCr, Cr, ATP H+
(calculated from the pH measured in the NMR spectrum)
and the Keq for creatine kinase (Veech et al., 1979). The
results shown in Table IV suggest that 10-20% of the total
tumour ADP is 'free', a value similar in order of magnitude
to that observed in kidney and liver (Freeman et al., 1983;
Iles et al., 1985).
Phosphate metabolite ratios in tissue overlying subcutaneously
implanted tumours
In three of the tumour types and at three or four points in
the growth studies, skin tissue overlying the tumours was
rapidly frozen. The data from the extracts suggest that there
is some correlation between PCr/Cr and PCr/NTP ratios in
the skin and the degree of skin invasion by the tumour. In
the Walker carcinosarcoma and mammary adenocarcinomas,
where histological evidence of skin invasion was observed
more often than not, the PCr/Cr ratios were 0.44 ± 0.15 and
0.41 0.12 respectively and the PCr/NTP ratios were
0.80 0.14 and 1.98 ± 0.43 respectively, considerably lower
than in normal skin (1.17 and 3.6; Stubbs et al., 1988a)
whereas in the prolactinomas where skin invasion was ob-
served only in one tumour of 17 cm3, the PCr/Cr and PCr/
NTP were higher: 1.54 ± 0.17 and 5.0 ± 1.3 respectively, both
slightly higher than the normal skin range. The changes in
the NTP/NDP ratios were not as clear cut but a change in
this ratio would be expected to be less marked than the
change in PCr/NTP due to the equilibrium position of the
creatine kinase reaction (McGilvery & Murray, 1974).
Discussion
The first tumour to be studied by NMR spectroscopy in vivo,
the Walker carcinosarcoma, gave spectra that sometimes
showed PCr (Griffiths & Stevens, 1981) and sometimes did
Table 11 High energy phosphates and Cr concentration in NMU-induced mammary
adenocarcinomas of different sizes
NMR measurements Acid extracts a
Size of Size of Cr conc.
tumour (cm3) PCr/PNTP PNTP/Pi tumour (cm3) PCr/NTP gmolg' wet wt
1.37 1.09 2.14 - - -
2.07 1.50 2.48 1.84 1.35 2.91
3.90 0 1.11 4.32 1.47 3.93
7.45 1.14 0.80 7.15 0.20 2.37
9.95 0 0.38 8.89 0.20 3.75
16.4 0 0.75 16.4 0.57 3.29
aMetabolite range (Jumolg-' wet wt) PCr, 0.21-1.85; NTP, 0.93-2.13.
-
t
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Table III Correlations between tumour volume and high energy/low energy
phosphate ratios in four tumour types
NMR measured ratios Acid extract ratios
Tumour type PCr/PNTP PiNTP/Pi PCr/NTP PCr/Cr NTP/NDP
Prolactinoma 0.75 0.85 0.74 0.78 0.76
(5) (5) (4) (4) (4)
P <0.02 <0.01 <0.05 <0.02 <0.05
Hepatoma - 0.99 - - 0.8
(3) (3)
P <0.001 <0.1
Mammary 0.63 0.75 0.59 0.98 0.57
(6) (6) (5) (4) (5)
P <0.05 <0.01 <0.1 <0.001 <0.1
Walker 0.023 0.27 0.33 0.2 0.012
(9) (9) (I1) (I1) (I 1)
P >0.1 >0.1 >0.1 >0.1 >0.1
Thedata are thecorrelation coefficients achievedwhencomparingtheratios
with tumour size. The closer the coefficient is to 1 the greater the correlation
between the decrease in high energy/low energy phosphate ratio compared to
the increase in tumour size.
a
15 1 5 0 - - - -
15 10 5 0 -5 -10 -1-5 -20
p.p.m.
Figure 3 31P-NMR spectrum and histology of a Walker Sarcoma. Details as Figure 1. a and b from a tumour 6.2 cm3.
Table IV Total and free ADP and Pi in tumours
Tumour type Total ADP Free ADP P value
Mammary (4) 0.58 ± 0.14 0.061 + 0.013 <0.02
Prolactinoma (3) 0.30 ± 0.1 0.056 ± 0.013 <0.02
Total Pi Free Pi
Mammary (5) 5.51 ± 1.4 1.76 0.46 <0.05
Walker (6) 5.10 ± 0.29 2.90 ± 0.50 <0.01
Theresults areexpressed asgmol g-' wetwtand aremean ± s.e.m. P
values compare total versus free metabolites. Total ADP and Pi were
measured in tumour extracts as described in the text. Free ADP was
calculated from ATP, PCr, and Cr measured in tumour extracts, pH
measured from the NMR spectra, and the Keq for creatine kinase
according to Veech et al. (1979). Free Pi was calculated from the
PNTP/Pi ratios measured from the NMR spectra making the simplify-
ing assumption that NTP measured in extracts was equal in concentra-
tion to the PNTP integral in the NMR spectra.
not (Griffiths et al., 1981). PCr was found in spectra of
mouse tumours (Ng et al., 1982) and in human xenografts
grown in mice (Griffiths & Iles, 1982). Furthermore, Ng et al.
(1982) showed that the PCr peak diminished during tumour
growth and that it became larger after chemotherapy.
The tumours in the present study fell into three classes
with respect to their PCr content. At one extreme the Morris
hepatoma 7777 showed no evidence of PCr or Cr in acid
extracts; the PCr signals observed in vivo in some of these
tumours (Stubbs et al., 1988a, 1989) were presumably caused
by skin contamination. The lack of PCr is probably because
hepatomas, like the hepatocyte from which they arise, do not
express creatine kinase (Shatton et al., 1979).
In contrast, the GH3 prolactinomas always contained PCr
and Cr in extracts and almost always showed a PCr signal in
vivo (Table I). The mammary adenocarcinomas also con-
tained Cr and varying amounts of PCr in all extracts, but
here three of the four largest tumours in a parallel series
showed negligible PCr signal in vivo (Table II).
The Walker carcinosarcomas fell into a third category. All
those studied by acid extraction contained PCr and Cr but
only about 50% of the NMR spectra showed signals in vivo,
explaining our earlier observations (Griffiths & Stevens, 1981;
Griffiths et al., 1982).
To what extent do other tissues contribute to the NMR
spectra?
First, NMR spectra taken with a surface coil include signals
from the tumour itself, from overlying tissues (Stubbs et al.,
1988a, 1989) and perhaps from underlying or laterally adja-
cent tissues. As skeletal muscle has an intense PCr signal,
PCr in a subcutaneous tumour spectrum is particularly
suspect. Under the conditions used in the present experiment
we think it unlikely that the surface coil detected significant
signals from underlying or laterally adjacent tissue (for dis-
cussion of this point see Griffiths et al., 1987). Extracts from
freeze-clamped skin and tumour can give specific information
on the possible contribution of PCr and Cr from those
compartments to the spectrum. For instance, these data can
tell us whether a tumour contains creatine compounds; if it
does not, any PCr signal in the NMR spectrum evidently
arises from overlying tissue as in the case of some hepatomas
(Stubbs et al., 1989 and this paper). However, because the
exact volume of skin that is in the field of the surface coil is
difficult to quantify due to the irregular radiofrequency fields706 M. STUBBS et al.
surface coils produce (Ackerman et al., 1980) it was not
possible to relate the skin extract data directly to the NMR
spectra. Precise localisation and quantitation techniques are
needed for this.
What does the 3'P-NMR spectrum ofa subcutaneously
implanted tumour tell us about the status ofthe tumour?
In three of the tumours studied here (mammary adenocar-
cinoma, GH3 prolactinoma and Morris Hepatoma 7777),
there was a tendency for the high energy/low energy phos-
phate ratios to decline as the tumours enlarged (Table III).
Thus these tumours show a decline in high energy phos-
phates (PNTP and PCr) relative to Pi with increasing tumour
size (see Glickson et al. (1989) for review) and PCr falls more
rapidly than PNTP. However, in the Walker carcinosarcoma
there was no correlation between high energy/low energy
phosphate ratios and size. Rofstad et al. (1988a) also found
one tumour, a human ovarian xenograft grown in athymic
mice, amongst four they studied, in which spectral para-
meters did not correlate with an increase in tumour volume.
No correlations between increasing tumour size and pH
were observed in any of the tumours. Such correlations have
previously been made in some tumours (Ng et al., 1982;
Adams et al., 1985; Rofstad et al., 1988a, 1988b) but not in
others (Rofstad et al., 1988a; Ross et al., 1988; Steen et al.,
1988; Rodrigues et al., 1988).
The fall in PCr usually seen in enlarging tumours has often
been attributed to PCr being used to synthesise ATP in cells
that were becoming hypoxic as a result of impaired tumour
circulation (Evanochko et al., 1984; Remy et al., 1987; Rofs-
tad et al., 1988a) and this is said to compensate for the
'inefficiency' of the glycolytic pathway as a source of ATP
(Rofstad et al., 1988; Evanochko et al., 1984; Remy et al.,
1987; Glickson et al., 1989).
ADP + PCr- ATP + Cr
creatine kinase
In practice, however, the amount of PCr in a tumour is far
too small (typically 1-2jmol g' wet weight) to make a
significant contribution to the ATP supply. Consider that
tumour ATP turnover is probably about 6pmol min-' g-':
conversion of all the PCr would supply ATP for only
10-20 s, whereas the fall in PCr concentration actually takes
place over a period of days, or even weeks.
What we observe in the 31P spectrum of a tumour is a
slowly changing steady state in which the concentrations of
the metabolites vary so as to maintain the maximum possible
rate of ATP synthesis despite a steady fall in cellular oxygen
concentration.
Do the 3'P-NMR changes that we, and others, have
observed in growing tumours reflect events in all the cells of
a tumour? Or do they occur only in the necrotic cells, with
the remainder being unaffected? This question has some prac-
tical importance: does 3'P-NMR tell us about the proportion
of the tumour that has become necrotic or does it tell us
about the metabolism of viable but hypoxic cells?
We can answer these questions for tumours such as the
GH3 prolactinoma and the NMU-induced mammary tumour
in the present study, and also for the MOPC 104E mouse
myeloma, described by Ng et al. (1982). In all these tumours
the PCr signal is lost before there is a significant fall in the
NTP peaks. This is clearly inconsistent with the hypothesis
that the changes occur only in cells that have become nec-
rotic, since necrotic cells have no NTP. If the tumour con-
sisted of normal cells with both PCr and NTP and necrotic
cells with neither PCr nor NTP one would observe a syn-
chronous fall in the PCr and NTP signals as the necrotic
fraction increased in the growing tumour. This was clearly
not the case in the NMU-induced mammary tumour or the
GH3 prolactinoma (see PCr/NTP ratios in Tables I and II),
and in the larger NMU-induced mammary tumours PCr was
undetectable despite strong NTP signals. Significant NTP
resonances have been reported (Ross et al., 1988) even when
there was 80-90% necrosis present in a C6 glioma, suppor-
ting the suggestion that the NMR signal comes from the
viable cells.
We can conclude, for these tumours at least, that the
3'P-NMR data tell us about the metabolic changes that occur
in viable cells, and thus in cells that may be the target of
therapy.
The authors would like to thank Dr S. Doak for histological pre-
paration and assessment.
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